A. Brian Jones

1.8k total citations
46 papers, 1.3k citations indexed

About

A. Brian Jones is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, A. Brian Jones has authored 46 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 13 papers in Organic Chemistry and 7 papers in Physiology. Recurrent topics in A. Brian Jones's work include Peroxisome Proliferator-Activated Receptors (8 papers), Chemical Synthesis and Analysis (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). A. Brian Jones is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (8 papers), Chemical Synthesis and Analysis (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). A. Brian Jones collaborates with scholars based in United States, United Kingdom and Spain. A. Brian Jones's co-authors include David E. Moller, Karen L. MacNaul, Joel P. Berger, Samuel J. Danishefsky, Thomas W. Doebber, John J. Acton, Harold B. Wood, James V. Heck, Regina M. Black and Lawrence F. Colwell and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

A. Brian Jones

43 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Brian Jones United States 21 727 452 217 157 145 46 1.3k
Christopher Fotsch United States 25 806 1.1× 931 2.1× 146 0.7× 77 0.5× 138 1.0× 48 1.8k
Frank Kayser United States 19 725 1.0× 692 1.5× 65 0.3× 139 0.9× 126 0.9× 33 1.4k
Stéphane De Lombaert United States 22 362 0.5× 599 1.3× 166 0.8× 33 0.2× 47 0.3× 49 1.2k
David Aharony United States 26 675 0.9× 307 0.7× 691 3.2× 66 0.4× 419 2.9× 63 1.8k
Steven M. Sparks United States 16 295 0.4× 690 1.5× 42 0.2× 83 0.5× 126 0.9× 25 980
Joseph P. Marino United States 34 604 0.8× 2.5k 5.5× 48 0.2× 44 0.3× 161 1.1× 112 3.2k
Kye Jung Shin South Korea 21 448 0.6× 680 1.5× 118 0.5× 72 0.5× 152 1.0× 82 1.4k
Shinji Terao Japan 21 461 0.6× 324 0.7× 342 1.6× 97 0.6× 328 2.3× 45 1.5k
De Lin United States 14 527 0.7× 133 0.3× 204 0.9× 57 0.4× 33 0.2× 23 1.1k
John W. Clader United States 28 953 1.3× 1.4k 3.1× 189 0.9× 325 2.1× 203 1.4× 72 3.1k

Countries citing papers authored by A. Brian Jones

Since Specialization
Citations

This map shows the geographic impact of A. Brian Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Brian Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Brian Jones more than expected).

Fields of papers citing papers by A. Brian Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Brian Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Brian Jones. The network helps show where A. Brian Jones may publish in the future.

Co-authorship network of co-authors of A. Brian Jones

This figure shows the co-authorship network connecting the top 25 collaborators of A. Brian Jones. A scholar is included among the top collaborators of A. Brian Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Brian Jones. A. Brian Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hodgetts, Kevin J., Charles A. Blum, Timothy M. Caldwell, et al.. (2010). Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites. Bioorganic & Medicinal Chemistry Letters. 20(15). 4359–4363. 10 indexed citations
2.
Elliott, Jason, Emma Carlson, Gary G. Chicchi, et al.. (2006). NK1 antagonists based on seven membered lactam scaffolds. Bioorganic & Medicinal Chemistry Letters. 16(11). 2929–2932. 15 indexed citations
3.
Elliott, Jason, Robert W. Carling, Gary G. Chicchi, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II. Bioorganic & Medicinal Chemistry Letters. 16(22). 5752–5756. 15 indexed citations
4.
Zheng, Xiaozhang, Kevin J. Hodgetts, Harry L. Brielmann, et al.. (2006). From arylureas to biarylamides to aminoquinazolines: Discovery of a novel, potent TRPV1 antagonist. Bioorganic & Medicinal Chemistry Letters. 16(19). 5217–5221. 25 indexed citations
5.
Elliott, Jason, Robert W. Carling, Mark S. Chambers, et al.. (2006). N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 16(22). 5748–5751. 35 indexed citations
6.
Liu, Kun, Regina M. Black, John J. Acton, et al.. (2005). Selective PPARγ modulators with improved pharmacological profiles. Bioorganic & Medicinal Chemistry Letters. 15(10). 2437–2440. 56 indexed citations
7.
Lewis, Stephen J., Adrian L. Smith, Joseph G. Neduvelil, et al.. (2004). A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core. Bioorganic & Medicinal Chemistry Letters. 15(2). 373–378. 35 indexed citations
8.
Acton, John J., Regina M. Black, A. Brian Jones, et al.. (2004). Benzoyl 2-methyl indoles as selective PPARγ modulators. Bioorganic & Medicinal Chemistry Letters. 15(2). 357–362. 105 indexed citations
9.
Adams, Alan D., Conrad Santini, A. Brian Jones, et al.. (2003). Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists. Bioorganic & Medicinal Chemistry Letters. 13(5). 931–935. 34 indexed citations
10.
Adams, Alan D., Alex Elbrecht, Karen L. MacNaul, et al.. (2003). O-Arylmandelic acids as highly selective human PPAR α/γ agonists. Bioorganic & Medicinal Chemistry Letters. 13(19). 3185–3190. 19 indexed citations
11.
Sparrow, Carl P., My‐Hanh Lam, Erik Lund, et al.. (2002). A Potent Synthetic LXR Agonist Is More Effective than Cholesterol Loading at Inducing ABCA1 mRNA and Stimulating Cholesterol Efflux. Journal of Biological Chemistry. 277(12). 10021–10027. 105 indexed citations
12.
Seabrook, Guy R., Kathy Sutton, Wolfgang Jarolimek, et al.. (2002). Functional Properties of the High-Affinity TRPV1 (VR1) Vanilloid Receptor Antagonist (4-Hydroxy-5-iodo-3-methoxyphenylacetate ester) Iodo-Resiniferatoxin. Journal of Pharmacology and Experimental Therapeutics. 303(3). 1052–1060. 108 indexed citations
13.
Jones, A. Brian. (2001). Peroxisome proliferator‐activated receptor (PPAR) modulators: Diabetes and beyond*. Medicinal Research Reviews. 21(6). 540–552. 56 indexed citations
14.
Qureshi, Sajjad A., Victor Ding, Zhihua Li, et al.. (2000). Activation of Insulin Signal Transduction Pathway and Anti-diabetic Activity of Small Molecule Insulin Receptor Activators. Journal of Biological Chemistry. 275(47). 36590–36595. 56 indexed citations
15.
16.
Jones, A. Brian, John J. Acton, Richard Cummings, et al.. (1999). Tetrapeptide derived inhibitors of complexation of a class II MHC: the peptide backbone is not inviolate. Bioorganic & Medicinal Chemistry Letters. 9(14). 2109–2114. 3 indexed citations
17.
Jones, A. Brian, John J. Acton, & George A. Doss. (1993). Selectivity in the dehydration of 15-membered azalides. Tetrahedron Letters. 34(31). 4913–4916. 3 indexed citations
18.
Jones, A. Brian, et al.. (1992). The in vitro profile of selected 14-membered azalides.. The Journal of Antibiotics. 45(11). 1785–1791. 3 indexed citations
19.
Jones, A. Brian. (1992). New macrolide antibiotics: synthesis of a 14-membered azalide. The Journal of Organic Chemistry. 57(16). 4361–4367. 16 indexed citations
20.
Greck, Christine, Peter Grice, A. Brian Jones, & Steven V. Ley. (1987). Synthesis of a novel 3, 4-dihydromilbemycin analogue.. Tetrahedron Letters. 28(46). 5759–5762. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher Fotsch Breakdown of academic impact, for papers by Frank Kayser Breakdown of academic impact, for papers by Stéphane De Lombaert Breakdown of academic impact, for papers by David Aharony Breakdown of academic impact, for papers by Steven M. Sparks Breakdown of academic impact, for papers by Joseph P. Marino Breakdown of academic impact, for papers by Kye Jung Shin Breakdown of academic impact, for papers by Shinji Terao Breakdown of academic impact, for papers by De Lin Breakdown of academic impact, for papers by John W. Clader
Rankless by CCL
2026